Cellectar Biosciences, Inc. - CLRB

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$1.037M
QoQ value delta ($000)
-$607K (-36.92%)
Implied price effect (QoQ)
-46.14%
Shares
Total shares
346,838
QoQ shares delta
+50,684 (+17.11%)
Total shares held by funds (by quarter)

Market chart (CLRB)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 29 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Bleichroeder LP 295 100,000 0.05%
VANGUARD GROUP INC 262 89,120 0.0%
DRW Securities, LLC 133 45,190 0.0%
GEODE CAPITAL MANAGEMENT, LLC 84 28,636 0.0%
Sequoia Financial Advisors, LLC 74 25,350 0.0%
Riverview Capital Advisers, LLC 50 10,384 0.02%
Warberg Asset Management LLC 41 13,900 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 36 12,204 0.0%
XTX Topco Ltd 36 12,243 0.0%
BlackRock, Inc. 13 4,745 0.0%
UBS Group AG 7 2,598 0.0%
Tower Research Capital LLC (TRC) 5 1,833 0.0%
MORGAN STANLEY 1 510 0.0%
US BANCORP \DE\ 0 3 0.0%
BANK OF AMERICA CORP /DE/ 0 36 0.0%
DANSKE BANK A/S 0 2 0.0%
JONES FINANCIAL COMPANIES LLLP 0 3 0.0%
OSAIC HOLDINGS, INC. 0 7 0.0%
SBI Securities Co., Ltd. 0 11 0.0%
TD Waterhouse Canada Inc. 0 63 0.0%